國家衛健委:昨日新增本土確診病例40例
格隆匯1月31日丨國家衛健委通報,1月30日0—24時,31個省(自治區、直轄市)和新疆生產建設兵團報告新增確診病例58例。其中境外輸入病例18例(上海10例,廣東7例,福建1例),含3例由無症狀感染者轉爲確診病例(均在廣東);本土病例40例(浙江24例,均在杭州市;天津11例,其中河北區8例、濱海新區3例;北京3例,其中豐臺區2例、朝陽區1例;黑龍江1例,在牡丹江市;河南1例,在汝州市),含1例由無症狀感染者轉爲確診病例(在河南)。無新增死亡病例。新增疑似病例3例,均爲境外輸入病例(均在上海)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.